Home
>
National Drug Code (NDC)
>
Victoza
Victoza - 0169-4060-12 - (liraglutide (rDNA origin) injection)
Drug Information of Victoza
| Product NDC: | 0169-4060 |
| Proprietary Name: | Victoza |
| Non Proprietary Name: | liraglutide (rDNA origin) injection |
| Active Ingredient(s): | 6 mg/mL & nbsp; liraglutide (rDNA origin) injection |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Victoza
| Product NDC: | 0169-4060 |
| Labeler Name: | Novo Nordisk |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022341 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100125 |
Package Information of Victoza
| Package NDC: | 0169-4060-12 |
| Package Description: | 2 SYRINGE, PLASTIC in 1 CARTON (0169-4060-12) > 3 mL in 1 SYRINGE, PLASTIC |
NDC Information of Victoza
| NDC Code | 0169-4060-12 |
| Proprietary Name | Victoza |
| Package Description | 2 SYRINGE, PLASTIC in 1 CARTON (0169-4060-12) > 3 mL in 1 SYRINGE, PLASTIC |
| Product NDC | 0169-4060 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | liraglutide (rDNA origin) injection |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20100125 |
| Marketing Category Name | NDA |
| Labeler Name | Novo Nordisk |
| Substance Name | LIRAGLUTIDE |
| Strength Number | 6 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | GLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [Chemical/Ingredient],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA] |
